This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gainer, J. V. Articles by Brown, N. J. Search for Related Content PubMed PubMed Citation Articles by Gainer, J. V. Articles by Brown, N. J. Related Collections ACE/Angiotension receptors Functional genomics Clinical Studies Endothelium/vascular type/nitric oxide

(Hypertension. 2001;37:46.)
© 2001 American Heart Association, Inc.

Scientific Contributions

Interactive Effect of Ethnicity and ACE Insertion/Deletion Polymorphism on Vascular Reactivity

James V. Gainer; C. Michael Stein; Tami Neal; Douglas E. Vaughan; Nancy J. Brown

From the Divisions of Clinical Pharmacology and Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Correspondence to James V. Gainer, M.D., 422 Medical Research Building-II, Vanderbilt University Medical Center, Nashville, TN 37232-6602. E-mail jay.gainer{at}mcmail.vanderbilt.edu

Abstract—Bradykinin is a potent endothelium-dependent vasodilator that contributes to the blood pressure lowering effect of angiotensin-converting enzyme inhibition. Angiotensin-converting enzyme inhibitors are widely prescribed for the treatment of hypertension, although the efficacy of this therapy has been reported to vary among different ethnic groups. To determine whether vascular sensitivity to bradykinin is decreased in blacks compared with whites, we measured forearm blood flow with venous plethysmography in response to intraarterially-administered bradykinin (100, 200, and 400 ng/min) under salt-controlled conditions in 28 (14 black, 14 white) normotensive subjects genotyped for the ACE insertion/deletion (I/D) polymorphism. Acetylcholine (ACh) (15, 30, and 60 µg/min) and sodium nitroprusside (SNP) (0.8, 1.6, and 3.2 µg/min) were infused as endothelium-dependent and endothelium-independent controls. Compared with whites, blacks exhibited a blunted vasodilator response to bradykinin (maximal blood flow: 20.4±2.5 versus 10.9±1.4 mL · 100 mL^-1 · min^-1, P=0.004) and SNP (14.1±1.6 versus 9.9±1.7 mL · 100 mL^-1 · min^-1, P=0.05) but not to ACh (10.5±2.8 versus 6.6±1.0 mL · 100 mL^-1 · min^-1, P=0.21). White subjects who carried at least 1 ACE D allele demonstrated significantly greater vasodilator responses to bradykinin compared with those homozygous for the I allele (DD or ID versus II, F=5.6, P<0.04). In contrast, only blacks homozygous for the ACE D allele had a significantly greater vasodilator response to bradykinin than those who carried the I allele (DD versus ID or II, F=8.3, P=0.01). The ethnic difference was most pronounced in subjects heterozygous at the ACE I/D locus in which blacks had a markedly attenuated response to bradykinin compared with whites (F=41.0, P<0.001). There was no effect of ACE I/D genotype on the vasodilator responses to SNP or ACh in either ethnic group. These data confirm that vascular reactivity to bradykinin and the endothelium-independent vasodilator SNP is decreased in normotensive blacks compared with whites, consistent with attenuated vascular smooth muscle reactivity. The data suggest that genetic variation at the ACE gene locus interacts with ethnicity to impact the vascular response to bradykinin.

Key Words: bradykinin • ethnicity • genetics • peptidyl-dipeptidase A • vasodilation

This article has been cited by other articles:

				E. Mata-Greenwood and D.-B. Chen Racial Differences in Nitric Oxide--Dependent Vasorelaxation Reproductive Sciences, January 1, 2008; 15(1): 9 - 25. [Abstract] [PDF]

				A.A. Lteif, K. Han, and K.J. Mather Obesity, Insulin Resistance, and the Metabolic Syndrome: Determinants of Endothelial Dysfunction in Whites and Blacks Circulation, July 5, 2005; 112(1): 32 - 38. [Abstract] [Full Text] [PDF]

				F. N. Witherow, P. Dawson, C. A. Ludlam, K. A. A. Fox, and D. E. Newby Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy J. Am. Coll. Cardiol., September 4, 2002; 40(5): 961 - 966. [Abstract] [Full Text] [PDF]

				D. A. Rosenbaum, M. Pretorius, J. V. Gainer, D. Byrne, L. J. Murphey, C. A. Painter, D. E. Vaughan, and N. J. Brown Ethnicity Affects Vasodilation, but Not Endothelial Tissue Plasminogen Activator Release, in Response to Bradykinin Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 1023 - 1028. [Abstract] [Full Text] [PDF]

				F. G. H. van der Kleij, P. E. de Jong, R. H. Henning, D. de Zeeuw, and G. Navis Enhanced Responses of Blood Pressure, Renal Function, and Aldosterone to Angiotensin I in the DD Genotype Are Blunted by Low Sodium Intake J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1025 - 1033. [Abstract] [Full Text]